EN DE
Check 35,000+ stocks against 26 valuation models and 37 quality factors
Data-driven stock valuation

YungShin Global Holding Corp (3705) fair value: what the stock is really worth

As of Sep 24, 2026: fair value of YungShin Global Holding Corp TWD 64.78, price TWD 56.00, upside +15.7%, quality 58 out of 100. Calculated from audited financials with 26 valuation models and 37 quality factors, updated daily.

  1. Fair value above price? Yes
  2. Good quality? Yes
  3. Add to watchlist

Healthcare · TW · ISIN TW0003705000

YG Broad data Sep 24, 2026

YungShin Global Holding Corp

3705 · TW

UndervaluedThe stock appears undervalued with acceptable quality.

✓Fair value 64.78 TWD · Undervalued (+16%)
!Quality 58/100
!Weak Growth (revenue 5y +0.7 %/yr)
!Thin margins · 9.9% net margin (TTM)
✓Low debt · generates free cash flow
·5.36% dividend yield
✓Ranks above peers (11/14)
!Moderate moat 46/100

What runs behind every stock

69 individual criteria per stock, every one traceable See the method →

Price vs Fair Value

62.03 TWD 28.08 TWD Fair Value 64.78 TWD Apr 2021 Sep 2026

White line = price, green steps = our fair value per fiscal year, dashed = 300-day average. As of Sep 24, 2026.

How to read this chart

60‑month range 28.08 TWD – 62.03 TWD · fair‑value band 43.11 TWD – 84.21 TWD · the 56.00 TWD price screens below the 64.78 TWD fair value. Dashed = 300-day average. As of Sep 24, 2026.

Follow YungShin Global Holding in your weekly email

Every Wednesday you see whether YungShin Global Holding is on track or worth a review, plus price against fair value. Free, up to 3 stocks.

We send you a confirmation link. Unsubscribe with one click.

Which stocks are undervalued right now? Check free Discover now →

Company profile

YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing.

Show more

YungShin Global Holding Corporation, through its subsidiaries, engages in investing, manufacturing, and sale of medicines, veterinary drugs, agricultural chemicals, industrial medicines, and cosmetics. It is also involved in the sale of medicine; trade, investment, and other related businesses; import and export trading; and food manufacturing. The company operates in Taiwan, the United States, Mainland China, and Japan. YungShin Global Holding Corporation was founded in 1952 and is based in Taipei, Taiwan.

Stock analysis

YungShin Global Holding Corp (3705) currently trades at 56.00 TWD, while our model-based Fair Value estimate is 64.78 TWD, implying the stock looks roughly 13.6% undervalued today.

Show more

Valuation

Bull case: the Multiples group reads highest at a median of 65.53 TWD per share, and 15 of the 26 models we run sit above the 56.00 TWD price.

Bear case: the Asset-Based group reads lowest at 20.52 TWD, and 11 of the 26 models stay below the price. Evidence for this calculation is high.

Scenario range: 43.11 TWD (bear) to 84.21 TWD (bull), the price of 56.00 TWD sits inside it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.

Quality & growth

The Quality Score stands at 58/100 (solid quality), in the Healthcare sector.

Weak Growth: Revenue growth is weak: less than 2 % a year.

YungShin Global Holding Corp reported revenue of 8.4B TWD in FY2025 versus 7.8B TWD in FY2021, a compound +1.8%/yr. Reported net income was 881M TWD in FY2025, compounding +4.6%/yr from FY2021.

Key figures

Market cap 16.1B TWD (≈ $504M) · P/E ratio 18.9 · P/S ratio 1.98 · EPS (TTM) 2.97 TWD · Dividend yield 5.4% · Net margin 10.5% · Return on equity 9.4% · Return on assets (EBIT) 8.5%.

Competitive moat

Our AI-assisted moat analysis scores the competitive advantage at 38 out of 100 (low confidence).

What moves the price

The share trades about 2% below its 52-week high and 14% above its 52-week low, currently above its 200-day average.

For context, the median of 10 Healthcare peers we cover trades at −8% fair-value upside, at 16%, 3705 screens cheaper than that median.

Fair Value models

Bear 43.11 TWD Fair Value 64.78 TWD Bull 84.21 TWD
Model ⓘEach model values the company its own way (discounted cash flow, earnings, assets, dividends). The fair value above is their evidence-weighted blend, not the output of a single model. Bear ⓘBear = the cautious scenario: the same model computed with conservative anchors (lower growth, margins and valuation multiples). Together with Bull it frames a plausible valuation range, not a price target.BaseBull ⓘBull = the optimistic scenario: the same model computed with favourable anchors (higher growth, margins and valuation multiples). Together with Bear it frames a plausible valuation range, not a price target. Evidence ⓘEvidence = how well-backed THIS model's estimate is for this stock (0–100): how complete and reliable its input data are, and how well the model fits the company. The final Fair Value is an evidence-weighted blend, so better-evidenced models count more. Green ≥70, amber 50–69, grey below 50.
Highest evidence
FCF DCF 37.51 TWD 54.09 TWD 76.38 TWD 81
Growth DCF 37.70 TWD 52.02 TWD 70.03 TWD 79
Owner Earnings 25.42 TWD 36.46 TWD 51.29 TWD 77
All 26 models by family
DCF Models
FCF DCF 37.51 TWD 54.09 TWD 76.38 TWD 81
Owner Earnings 25.42 TWD 36.46 TWD 51.29 TWD 77
5Y Revenue Exit 41.40 TWD 65.71 TWD 96.77 TWD 72
5Y EBITDA Exit 49.51 TWD 80.96 TWD 117.73 TWD 74
5Y P/E Exit 44.82 TWD 72.13 TWD 100.84 TWD 70
10Y Revenue Exit 38.20 TWD 58.74 TWD 86.37 TWD 66
10Y EBITDA Exit 44.09 TWD 68.44 TWD 101.05 TWD 68
10Y P/E Exit 41.35 TWD 62.83 TWD 89.22 TWD 64
Earnings-Based
Graham-Dodd 22.49 TWD 72.04 TWD 96.08 TWD 64
Lynch FV 15.95 TWD 22.78 TWD 29.62 TWD 61
PEG = 1.0 15.95 TWD 22.78 TWD 29.62 TWD 57
EPV 30.20 TWD 34.14 TWD 37.42 TWD 74
Dividend Discount
Gordon GGM 25.10 TWD 45.23 TWD 62.27 TWD 68
DDM Multi-Stage 25.10 TWD 39.54 TWD 48.32 TWD 67
Multiples
P/E Multiple 54.56 TWD 72.75 TWD 90.94 TWD 63
P/S Multiple 42.16 TWD 56.22 TWD 70.27 TWD 58
P/B Multiple 42.16 TWD 56.22 TWD 70.27 TWD 55
EV/EBIT 64.29 TWD 85.28 TWD 106.27 TWD 66
EV/EBITDA 64.70 TWD 85.83 TWD 106.95 TWD 67
EV/Revenue 46.27 TWD 65.53 TWD 84.79 TWD 54
Asset-Based
NCAV (Graham) 15.31 TWD 20.52 TWD 30.63 TWD 54
Growth DCF
Growth DCF 37.70 TWD 52.02 TWD 70.03 TWD 79
Rev-Margin DCF 41.40 TWD 65.69 TWD 93.79 TWD 72
Economic Profit
Residual Income 26.15 TWD 28.74 TWD 35.61 TWD 76
ROIC Compounder 30.20 TWD 35.79 TWD 42.48 TWD 72
Growth Earnings
Growth-Adj P/E 45.34 TWD 64.78 TWD 84.21 TWD 67

Open the full fair value analysis →

Notify me when 3705 reaches fair value

Put 3705 on your watchlist. We get in touch as soon as price and fair value meet or the trend turns.

Set up alert →

Quality Score breakdown

Overall quality 58/100

Of which business quality 59 · Market factors (momentum, volatility) 68

Profitability 49
Margins and returns on capital today
Quality Growth 40
Are margins and returns improving?
Cashflow 64
Earnings quality: real cash, not paper profit
Fin. Strength 85
Balance sheet, leverage, solvency risk
Investment 82
Disciplined investing over empire-building
Low Volatility 100
Calm price path (market factor)
Momentum 50
Price trend over the last 3–12 months (market factor)
52W Momentum 62
Distance to the 52-week high (market factor)
Net Issuance 31
Share count: buybacks or dilution?

Open the full quality analysis →

Revenue & earnings trend

Growth Quality ⓘGrowth is valuable only when reinvestment earns attractive returns (Aswath Damodaran): sustainable growth depends on return on capital, reinvestment and efficiency. Basis: total company revenue over the periods shown on the cards (3Y/5Y/all years), not per share, so a merger can show up as a growth jump; per-share earnings growth is in the value-creation card. 40/100
Revenue growth is weak: less than 2 % a year.
Revenue growth 1 year
+4.3%
Revenue growth 3 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.6%
Revenue growth 5 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+0.7%
Start year 2020 (pandemic). Over 10 years: +3.3% a year
Revenue growth 25 years ⓘMeasures the company's TOTAL revenue from reported annual statements: compound average growth per year (CAGR) from the fiscal year 3, 5 or N years back to the most recent comparable fiscal year. Not per share: buybacks do not change this number, and a merger can appear as a growth jump. Per-share growth (which does include buybacks) is in the value-creation card.
+4.5%
What shareholders gained per year (last 5 years), in TWD ⓘWhat the business itself delivers per year: earnings growth per share plus the dividend yield. This is what you get IF the market keeps valuing the stock the same way: it contains no assumption about the market changing its mind. Computed per share, so buybacks count and a merger does not pass as growth. For a company that pays no dividend it is pure earnings growth per share. Period: earnings growth per share as CAGR over the last 5 reported fiscal years (annual statements), plus the current dividend yield. The start value is the median of the three years around the start, so a single crisis year (a pandemic or a write-down) does not distort the rate. Measured in TWD: this currency has depreciated against the euro and dollar over the long run, so part of the nominal rate is currency erosion that never reaches a EUR/USD investor.
+7.2%
Earnings growth per share plus dividend.
Earnings per share, growth per year+1.8%
Dividend (yield on the price)5.4%
Pace: 5 vs 10 years ⓘTwo data points, not a trend model: earnings growth per share over the last 5 fiscal years against the last 10. Labelled "steady" when both rates are within 3 percentage points of each other, otherwise picking up or flattening. Shown only when ten years of history exist.2% vs 1%, steady
Profit margin 2020 to 2025 ⓘOperating margin then vs now, from reported annual statements. A falling margin after a boom year is the classic peak-earnings signal: the growth rate then leans on an inflated base.13% → 16%
Start year 2020 (pandemic)

Growth Forecast

A lot of optimism in the price
The price assumes more growth than the company has delivered so far.
What the price assumes ⓘThis turns our valuation around: instead of asking what the share is worth, it asks what growth the current price requires. It uses the cash the company keeps after all spending (free cash flow), the same discount rate as our models, five years of growth, then slowing evenly to 2 % a year by year ten. Compared with the analysts' sales forecasts extended to the same five years (at least three analysts, for context only, it does not enter the Fair Value): within 3 percentage points counts as "in line" (amber), below that little optimism (green), above that a lot of optimism (red).
+5.3%
Yearly growth needed for the next five years to justify today's price.
What forecasts expect
n/a
No analyst forecast available.
After inflation (Taiwan: IMF forecast 1.6% a year to 2030, 1.5% from 2016 to 2025) that is about +3.6% a year for the price.

Watch 3705, get fair value alerts →

Compare YungShin Global Holding Corp with another stock

Price, fair value, quality and upside side by side.

Free, no sign-up

Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Drug Manufacturers - Specialty & Generic · 626 stocks

Beats the industry median on 11/14 measures
Overall it ranks above its industry peers.
Valuation
Quality Score 58 · Above median
Fair Value upside +16% · Above median
Profitability
Return on equity (TTM) 9% · Above median
Return on assets 6% · Above median
Net margin (TTM) 10% · Above median
Operating margin (TTM) 16% · Above median
Growth and dividend
Revenue growth −16% · Bottom 25%
Dividend yield (TTM) 5.4% · Top 25%
Balance sheet
Debt / equity 0.10× · Above median

Valuation Multiplesvs Drug Manufacturers - Specialty & Generic median · lower = cheaper

P/E (TTM) 18.9× · Cheaper than median
P/B 1.97× · Pricier than median
P/S (TTM) 2.00× · Cheaper than median
P/FCF 0.5× · Cheaper than median
EV/EBITDA 10.6× · Cheaper than median

Strength profile in five axes (Snowflake)

VALUEFUTUREPASTHEALTHDIVIDEND
This stock
VALUEFUTUREPASTHEALTHDIVIDEND
Sector peers
VALUE (fair-value potential)54 · sector 14
FUTURE (revenue growth)0 · sector 21
PAST (return on equity)38 · sector 27
HEALTH (low debt)95 · sector 96
DIVIDEND (yield)100 · sector 32

Context: sector, industry, market

Values & ESG

Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.

None of the checked exposures detected

Similar stocks

10 more Drug Manufacturers - Specialty & Generic stocks, each showing price versus our Fair Value estimate.

Stock Price Fair Value vs Fair Value
Merck KGaA MRK €133.15 €108.70 −18%
Takeda Pharmaceutical Company TAK $18.95 $11.29 −40%
Jiangsu Hengrui Pharmaceuticals Co 600276 ¥45.58 ¥50.14 +10%
Sun Pharmaceutical Industries Limited SUNPHARMA ₹1,865 ₹1,979 +6%
Galderma Group GALD CHF 163.80 CHF 109.88 −33%
Haleon plc HLN $9.25 $8.50 −8%
Teva Pharmaceutical Industries Limited TEVA $39.52 $20.75 −47%
Sandoz Group SDZ CHF 70.76 CHF 40.16 −43%
Zoetis Inc ZTS $72.86 $108.48 +49%
Hansoh Pharmaceutical Group 3692 HK$35.34 HK$38.87 +10%

Explore undervalued stocks

More undervalued Healthcare stocks →

All undervalued stocks TechnologyFinancial ServicesHealthcareConsumer CyclicalConsumer DefensiveCommunication ServicesIndustrialsEnergyBasic MaterialsReal EstateUtilities Deeply Undervalued StocksUndervalued High-Quality StocksUndervalued Blue-Chip StocksUndervalued Small-Cap StocksUndervalued Dividend Stocks

Try a ready-made strategy

Pick a strategy and jump into the live analysis with that exact screen applied.

🥇 Backtested Best 🏆 Big Names ⭐ Top Rated 💎 Quality on Sale 🚀 Profitable Growth 🧊 Quality Compounders 💵 Dividend Stars 📈 Strong Momentum 📉 Fallen Angels ⚖️ Deeply Undervalued 🔍 Small-Cap Gems 🏰 Moat at a Fair Price 💼 Insider Buying 🎩 Buffett-Style Quality 📚 Peter Lynch GARP 🧮 Greenblatt Magic Formula 🛡️ Graham Defensive

Discover tools

For bloggers & editors: embed code + live data

For bloggers, editors and developers: paste this into your site or blog (a “Custom HTML” block in WordPress), it shows the current fair value and links back here. Free, plain HTML, and welcome. Full data streams (CSV/JSON) at /developers.

Cite: Fair Value Calculator (2026). "YungShin Global Holding Corp Fair Value". https://www.fairvalue-calculator.com/stock/3705

Frequently asked questions

Is YungShin Global Holding Corp (3705) overvalued or undervalued?
As of Sep 24, 2026, our model estimates a fair value of 64.78 TWD versus a price of 56.00 TWD, about +16% upside (undervalued).
What is the fair value of 3705?
Our model-based fair value for YungShin Global Holding Corp is 64.78 TWD (as of Sep 24, 2026), built from audited fundamentals. The current price: 56.00 TWD.
What is the quality score of 3705?
YungShin Global Holding Corp has a Quality Score of 58/100. It measures business quality (profitability, growth, cash flow, balance-sheet strength, investment discipline, share issuance). Market factors such as price momentum and volatility do not enter the number; they are shown separately in the detail view.
What is the price target for YungShin Global Holding Corp (3705)?
Our model-based price target is the fair value of 64.78 TWD (as of Sep 24, 2026) from 26 valuation models. Cautious scenario 43.11 TWD, optimistic scenario 84.21 TWD. It is a calculation from audited fundamentals, not an analyst target.
What is the YungShin Global Holding Corp stock forecast for 2026?
Our models put fair value at 64.78 TWD, about +16% upside versus a price of 56.00 TWD (undervalued). Cautious scenario 43.11 TWD, optimistic scenario 84.21 TWD. The calculation is refreshed regularly with new filings.
What is the revenue of YungShin Global Holding Corp (3705)?
YungShin Global Holding Corp reported trailing-twelve-month revenue of about 8.0B TWD (latest available figure, as of Sep 24, 2026).
Does YungShin Global Holding Corp pay a dividend?
YungShin Global Holding Corp currently shows a dividend yield of about 5.36% relative to its recent price (as of Sep 24, 2026).
What growth is priced into YungShin Global Holding Corp (3705)?
For today's price to be fair in a discounted-cash-flow model, YungShin Global Holding Corp would have to grow free cash flow by +5.3 % per year for five years (discount rate 10.3 %, then slowing evenly to 2 % perpetual growth by year ten). Over the last 5 years revenue grew +0.7 % per year. As of Sep 24, 2026.
What discount rate (WACC) does the fair value of 3705 use?
Our models discount YungShin Global Holding Corp at 10.3 %: a base by market capitalisation (small), damped by beta 0.08, country premium for Taiwan. The same rate applies in all 26 models.
What is a reverse DCF?
A reverse DCF turns the usual calculation around. Instead of deriving a value from assumptions, it takes today's price as given and asks: what free-cash-flow growth would a company have to deliver for exactly this price to be fair? The result is not a forecast but the expectation already priced in. For YungShin Global Holding Corp that is +5.3 % per year a year over ten years, using the same discount rate (10.3 %) and the same formula as our fair value.
How much growth has YungShin Global Holding Corp (3705) delivered so far?
Over the past 5 years revenue at YungShin Global Holding Corp grew +0.7 % a year. The price currently implies +5.3 % per year free-cash-flow growth a year. Comparing the two shows how much confidence is in the price: if it demands more than has been delivered, the business has to accelerate for the maths to work.
How fast is the sector of YungShin Global Holding Corp (3705) growing?
The median revenue growth in the sector is +4.2 % a year. That is the yardstick for the growth priced into YungShin Global Holding Corp (+5.3 % per year a year): it shows whether the expectation is within the usual range or beyond it.
What is the free cash flow yield of YungShin Global Holding Corp (3705)?
The free-cash-flow yield on the price is 6.26 %: that much free cash flow YungShin Global Holding Corp produces per unit of market value. When it exceeds the discount rate of our models (10.3 %), the business already earns more than its cost of capital demands, and the price needs little additional growth.
What is the intrinsic value of YungShin Global Holding Corp (3705)?
Intrinsic value and fair value mean the same thing: what the business is worth on its numbers, independent of the share price. For YungShin Global Holding Corp it is 64.78 TWD per share (as of Sep 24, 2026), against a price of 56.00 TWD. It is the blended result of 26 valuation models (cash flow, earnings, asset, dividend).
Is YungShin Global Holding Corp stock overvalued or undervalued in 2026?
As of Sep 24, 2026, 3705 trades below its calculated fair value: price 56.00 TWD, fair value 64.78 TWD, a gap of about +16% (undervalued). The calculation is refreshed with each new quarterly report, so the verdict can change during the year.
Is fair value the same as the market price of 3705?
No. The price is what the market pays today (56.00 TWD); the fair value is what the company's own numbers justify (64.78 TWD). For YungShin Global Holding Corp the two are 8.78 TWD per share apart. That gap is exactly why we show both numbers side by side.
How much is YungShin Global Holding Corp worth?
The market values YungShin Global Holding Corp at about 16.1B TWD (market capitalisation, as of Sep 24, 2026). Per share that is 56.00 TWD; our models calculate a fair value of 64.78 TWD per share.
What do the bullish and bearish scenarios say about 3705?
Our models span a range for YungShin Global Holding Corp: cautious scenario 43.11 TWD, base 64.78 TWD, optimistic 84.21 TWD per share (as of Sep 24, 2026, price 56.00 TWD). The range comes from different growth and margin assumptions, not from analyst opinions.
What is the P/E ratio of 3705?
YungShin Global Holding Corp trades at a price-to-earnings ratio of 18.9 (as of Sep 24, 2026). A P/E on its own says little: it compares the price with ONE year of profit, while our fair value of 64.78 TWD is built from several models across several years. Other multiples: P/B 2.0, P/S 2.0, EV/EBITDA 10.6.
How solid is the balance sheet of YungShin Global Holding Corp (3705)?
Balance-sheet figures for YungShin Global Holding Corp (as of Sep 24, 2026): return on equity 9.4%, debt of 0.10 per unit of equity. They feed the Quality Score of 58/100, which measures business quality independently of the share price.
How far is 3705 from its 52-week high?
YungShin Global Holding Corp trades at 56.00 TWD, about 2% below its 52-week high of 57.40 TWD and 14% above the low of 49.26 TWD (as of Sep 24, 2026). Distance from the high says nothing about value: that is what the fair value of 64.78 TWD is for.
Which stocks are comparable to YungShin Global Holding Corp?
From the same area (Healthcare) we also value Merck KGaA, Takeda Pharmaceutical Company, Jiangsu Hengrui Pharmaceuticals Co, Sun Pharmaceutical Industries Limited, among others. Each of them has its own fair-value calculation on this site using the same models, so the comparison is like for like.
Is YungShin Global Holding Corp stock attractive at the current price?
The data as of Sep 24, 2026: price 56.00 TWD, calculated fair value 64.78 TWD (+16%), Quality Score 58/100, from 26 models. Whether that fits your horizon and risk tolerance is your call. We provide the calculation, not investment advice.
How is the fair value of 3705 calculated?
We run YungShin Global Holding Corp through 26 models from four families: discounted cash flow, earnings models, asset and balance-sheet models, and dividend models. Every model gets the same audited fundamentals; the result is the weighted average of 64.78 TWD, with the spread shown as a cautious and an optimistic scenario.
Is it still worth investing in stocks now?
The global stock market currently sits 14.1 % above its aggregate fair value. YungShin Global Holding Corp currently trades 16 % below its own fair value, and the market average says nothing about that. An expensive market is no reason to stay out and no reason to buy everything at once: keep a broad savings plan running, buy single stocks only with money you can do without, and hold part of your money liquid while the market is high. The full picture including sectors is on is it worth investing now.
What is the share price of YungShin Global Holding Corp (3705)?
The closing price on Sep 24, 2026 was 56.00 TWD. Our model-based fair value is 64.78 TWD, about +16% upside (undervalued). We carry closing prices from our data provider, not a live tick.
What should I pay attention to with YungShin Global Holding Corp right now?
A fairly wide model range (43.11 TWD to 84.21 TWD) leaves room in how you read the outcome. The price sits in the lower half of our model range, the side with the larger margin of safety. The data supports the verdict: every model runs on fully documented inputs.
Where does the earnings growth of YungShin Global Holding Corp (3705) come from?
Earnings per share at YungShin Global Holding Corp grew +2.4 % a year from 2014 to 2025. Broken into its drivers: revenue per share +2.7 %, EBIT margin +2.5 %, tax rate −0.7 %, residual (interest, one-offs) −1.9 %. The four rates multiply to the earnings growth rate, they do not add up. Start and end are three-year averages so a single exceptional year does not distort the result.

Key figures of YungShin Global Holding Corp

How large is the market capitalisation of YungShin Global Holding Corp (3705)?
The market capitalisation of YungShin Global Holding Corp is 16.1B TWD (≈ $504M). The stock-market value of the whole company: share price times number of shares. It is what the market asks for the entire business today.
What is the P/S ratio of YungShin Global Holding Corp (3705)?
The price-to-sales ratio of YungShin Global Holding Corp is 1.98 (P/E × margin). Price to sales: market value relative to yearly revenue. Useful when profit is thin or distorted.
What are the earnings per share of YungShin Global Holding Corp (3705)?
Earnings per share at YungShin Global Holding Corp are 2.97 TWD (price ÷ EPS = P/E 18.9). Earnings per share over the last twelve months: total profit spread across every single share.
What is the dividend yield of YungShin Global Holding Corp (3705)?
The dividend yield of YungShin Global Holding Corp is 5.4% (payout 101%). Yearly dividend relative to the share price. 3% pays 3 per 100 invested. Below: how much of profit is used for it.
What is the net margin of YungShin Global Holding Corp (3705)?
The net margin of YungShin Global Holding Corp is 10.5% (fiscal year 2025). How much of every unit of revenue ends up as profit. 10% means 10 cents of profit per dollar of sales.
What is the return on equity of YungShin Global Holding Corp (3705)?
The return on equity (ROE) of YungShin Global Holding Corp is 9.4% (last twelve months). Profit relative to shareholders' equity, how efficiently the company works with its owners' money.
What is the EBIT return on assets of YungShin Global Holding Corp (3705)?
On an EBIT basis the return on assets of YungShin Global Holding Corp is 8.5% (avg 5y). Operating profit (EBIT) relative to everything the company owns, as a multi-year average. It describes the business model rather than one good or bad year.
What is the operating margin of YungShin Global Holding Corp (3705)?
The operating margin of YungShin Global Holding Corp is 16.2% (last twelve months). Profit from the core business (before interest and taxes) relative to revenue.
How fast is revenue growing at YungShin Global Holding Corp (3705)?
Revenue at YungShin Global Holding Corp is growing −15.5% versus a year earlier (3y avg +4.6%). How much revenue grew versus a year earlier (YoY). The 3-year average next to it puts the single year in context.
How fast are earnings growing at YungShin Global Holding Corp (3705)?
Earnings per share at YungShin Global Holding Corp are growing −27.4% versus a year earlier. How much earnings per share grew versus a year earlier.
How much net cash does YungShin Global Holding Corp (3705) hold?
YungShin Global Holding Corp holds more cash than debt, 15.6M TWD net (fiscal year 2025). The company holds more cash than debt, a safety cushion.
Free · no account needed

Watch YungShin Global Holding Corp in the live analysis

One click puts YungShin Global Holding Corp on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 35,000+ stock screener. You can also try 14 days of Pro there, no card.

Watch for free →

Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.